![Syed Rizvi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Syed Rizvi
Technik-/Wissenschafts-/F&E-Leiter bei
POSEIDA THERAPEUTICS, INC.
Vermögen: 1 Mio $ am 31.05.2026
Profil
Syed Rizvi is currently Chief Medical Officer at Poseida Therapeutics, Inc. starting in 2024 and at Rocket Pharmaceuticals, Inc. starting in 2025.
Memberships include American Society of Clinical Oncology, Inc., American Society of Hematology, and The European Hematology Association.
Former roles include Chief Medical Officer at Caribou Biosciences, Inc. from 2022 to 2023, Chief Medical Officer at Chimeric Therapeutics Ltd. (Australia) from 2020 to 2022, VP-Clinical Development & Medical Affairs at Legend Biotech Corp.
from 2018 to 2020, and Head-Global Medical Affairs at Celgene Corp.
Education includes a doctorate from Dow Medical College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.02.2026 | 407.874 ( 0,37 % ) | 1 Mio $ | 31.05.2026 |
Aktive Positionen von Syed Rizvi
| Unternehmen | Position | Beginn |
|---|---|---|
| POSEIDA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2024 |
| ROCKET PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2025 |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Corporate Officer/Principal | - |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Corporate Officer/Principal | - |
The European Hematology Association
 The European Hematology Association Miscellaneous Commercial ServicesCommercial Services Engages in promoting patient care, research and education in hermatology | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Syed Rizvi
| Unternehmen | Position | Ende |
|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 31.12.2023 |
| CHIMERIC THERAPEUTICS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | - |
| LEGEND BIOTECH CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2020 |
| CELGENE | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Syed Rizvi
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
81
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Caribou Biosciences, Inc.
 Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Commercial Services |
The European Hematology Association
The European Hematology Association Miscellaneous Commercial ServicesCommercial Services Engages in promoting patient care, research and education in hermatology | Commercial Services |
Dow Medical College
 Dow Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Poseida Therapeutics, Inc.
 Poseida Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops next generation cell and gene therapeutics | Health Technology |
Legend Biotech Corp.
 Legend Biotech Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which engages in the discovery and development of novel cell therapies for oncology | Health Technology |
Rocket Pharmaceuticals, Inc.
 Rocket Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Chimeric Therapeutics Ltd. (Australia)
 Chimeric Therapeutics Ltd. (Australia) BiotechnologyHealth Technology Develops cell therapies for the tumors | Health Technology |
